168. Intradermal immunization drives humoral and cellular immunity to the lung and protects against acute P. aeruginosa pneumonia
Session: Oral Abstract Session: Science Relevant to ID
Thursday, October 4, 2018: 11:30 AM
Room: S 157
Background: Pseudomonas aeruginosa is a leading cause of hospital-associated pneumonia, with 6700 multidrug-resistant infections in the US annually. Evidence suggests that antibodies and CD4 Th1 and Th17 responses contribute to protection against P. aeruginosa infection. Recent work suggests that intradermal (ID) immunization with a vaccine adjuvanted with a double mutant of E. coli heat-labile toxin (dmLT) can direct protective immune responses to mucosal tissues such as the lungs. We sought to determine if ID immunization with P. aeruginosa outer membrane proteins (OMPs) with dmLT could drive migration of CD4+ T cells and antibodies to the lungs and protect against P. aeruginosa pneumonia.

Methods: We immunized C57Bl/6 mice with 1 µg of OMPs with 1 µg dmLT. Control mice received OMPs or saline. Antibody and T cell responses were assessed by ELISA and flow cytometry, respectively. We then evaluated the protective efficacy of the vaccine in a lethal acute pneumonia model. Immunized mice were challenged with 7x106 CFU of P. aeruginosa via oropharyngeal aspiration into the lungs. Finally, we examined if memory CD4+ T cells were essential for protection by depleting immunized mice of vaccine-induced memory CD4+ T cells.

Results: Mice immunized with OMPs and dmLT had a significantly greater concentration of anti-pseudomonal IgG in the serum and lungs and a significantly greater proportion of CD4+ T cells in the lung producing IFN-γ or IL-17A than mice immunized with OMPs alone or saline. ID immunization provided significant protection against P. aeruginosa pneumonia, with 78% of immunized mice surviving compared to 100% mortality in saline immunized controls. Memory CD4+ T cell-depleted mice displayed reduced survival (40%) compared to non-depleted mice (80%), confirming that memory CD4 T+ cells contribute to OMP-dmLT vaccine-mediated protection.

Conclusion: These results demonstrate that ID vaccination against P. aeruginosa protects against acute lethal P. aeruginosa pneumonia by stimulating antigen-specific IgG and Th1- and Th17-type CD4+ memory T cells in the pulmonary milieu. ID immunization with dmLT may reduce the global morbidity and mortality caused by multidrug resistant respiratory pathogens.

Sarah Baker, BSPH, MSc and Lisa Morici, PhD, Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA

Disclosures:

S. Baker, None

L. Morici, None

See more of: Science Relevant to ID
See more of: Oral Abstract Session
<< Previous Abstract | Next Abstract

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.